Because pulmonary metastasis of PDPN-positive bladder cancer cells was reduced by the knockdown of PDPN and the administration of anti-PDPN neutralizing antibodies in mice models [42], targeting platelet–cancer cell interactions would be promising for an antimetastatic approach. This evidence concerns the gene PDPN and urinary bladder cancer.